These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 39084836)
1. Newer Therapies in Rheumatology. Bays A; Gardner GC Med Clin North Am; 2024 Sep; 108(5):829-842. PubMed ID: 39084836 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapies in rheumatologic disorders. Miller AV; Ranatunga SK Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852 [TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. Shepherd J; Cooper K; Harris P; Picot J; Rose M Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404 [TBL] [Abstract][Full Text] [Related]
4. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J Arthritis Rheumatol; 2019 Jan; 71(1):5-32. PubMed ID: 30499246 [TBL] [Abstract][Full Text] [Related]
5. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare. Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675 [TBL] [Abstract][Full Text] [Related]
6. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934 [TBL] [Abstract][Full Text] [Related]
7. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study. Wu N; Lee YC; Shah N; Harrison DJ Clin Ther; 2014 Aug; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study. Pappas DA; St John G; Etzel CJ; Fiore S; Blachley T; Kimura T; Punekar R; Emeanuru K; Choi J; Boklage S; Kremer JM Ann Rheum Dis; 2021 Jan; 80(1):96-102. PubMed ID: 32719038 [TBL] [Abstract][Full Text] [Related]
10. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis. Do H; Babbush Graber K; Chernoff KA; Melnick LE Dermatol Clin; 2024 Jul; 42(3):377-386. PubMed ID: 38796269 [TBL] [Abstract][Full Text] [Related]
11. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242 [TBL] [Abstract][Full Text] [Related]
12. Biologic interventions for fatigue in rheumatoid arthritis. Almeida C; Choy EH; Hewlett S; Kirwan JR; Cramp F; Chalder T; Pollock J; Christensen R Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008334. PubMed ID: 27271314 [TBL] [Abstract][Full Text] [Related]
13. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Rivière E; Sellam J; Pascaud J; Ravaud P; Gottenberg JE; Mariette X Arthritis Res Ther; 2018 Jun; 20(1):122. PubMed ID: 29884223 [TBL] [Abstract][Full Text] [Related]
14. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo MA; Ghogomu ET; Tugwell P CMAJ; 2009 Nov; 181(11):787-96. PubMed ID: 19884297 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases. Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082 [TBL] [Abstract][Full Text] [Related]
16. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462 [TBL] [Abstract][Full Text] [Related]
17. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom. Nisar MK; Rafiq A; Östör AJ Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501 [TBL] [Abstract][Full Text] [Related]
18. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438 [TBL] [Abstract][Full Text] [Related]
19. [Mechanism of action of biological disease--modifying antirheumatic drugs]. Takahashi N; Ishiguro N Nihon Rinsho; 2016 Jun; 74(6):882-6. PubMed ID: 27311173 [No Abstract] [Full Text] [Related]
20. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response. Gibbons LJ; Hyrich KL BioDrugs; 2009; 23(2):111-24. PubMed ID: 19489652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]